Alkem Laboratories (NSE:ALKEM) Other Long Term Assets: ₹ Mil (As of Jun. 2026)

Author: Vera Yuan Vera Yuan
Vera Yuan
Vera Yuan
Director of Data and Quant Analytics at GuruFocus
Focused on building reliable datasets, financial models, and research tools for value-minded investors. Committed to turning complex data into practical guidance for value-investing and long-term wealth.
Reviewed by: Charlie Tian Charlie Tian
Charlie Tian
Charlie Tian
Founder & CEO of GuruFocus
Dr. Charlie Tian is the founder and CEO of GuruFocus.com, a leading global investment research platform established in 2004. With a Ph.D. in physics, Dr. Tian transitioned from science to finance, applying a data-driven, disciplined approach to value investing.

NSE:ALKEM Alkem Laboratories Ltd NSE:ALKEM
96 GF Score
Price ₹5,466.50
GF Value ₹6,174.95
Valuation Modestly Undervalued
View Full Analysis

What is Alkem Laboratories Other Long Term Assets?

Alkem Laboratories NSE:ALKEM +2.21% 96 Other Long Term Assets is ₹ Mil as of Jun. 2026. GuruFocus rates NSE:ALKEM with a GF Score™ of 96/100 and a GF Value™ of ₹6,174.95 (Modestly Undervalued).

Alkem Laboratories's other long-term assets for the quarter that ended in Jun. 2026 was ₹ Mil.

Alkem Laboratories's quarterly other long-term assets increased from Dec. 2025 (₹ Mil) to Mar. 2026 (₹29,931 Mil) but then stayed the same from Mar. 2026 (₹29,931 Mil) to Jun. 2026 (₹ Mil).

Alkem Laboratories's annual other long-term assets increased from Mar. 2024 (₹19,437 Mil) to Mar. 2025 (₹23,248 Mil) and increased from Mar. 2025 (₹23,248 Mil) to Mar. 2026 (₹29,931 Mil).

Alkem Laboratories Other Long Term Assets Historical Data

* Premium members only.

The historical data trend for Alkem Laboratories's Other Long Term Assets can be seen below:

* For Operating Data section: All numbers are indicated by the unit behind each term and all currency related amount are in USD.
* For other sections: All numbers are in millions except for per share data, ratio, and percentage. All currency related amount are indicated in the company's associated stock exchange currency.

Alkem Laboratories Other Long Term Assets Chart

Alkem Laboratories Annual Data
Trend Mar17 Mar18 Mar19 Mar20 Mar21 Mar22 Mar23 Mar24 Mar25 Mar26
Other Long Term Assets
Get a 7-Day Free Trial Premium Member Only Premium Member Only 16,680.40 17,670.50 19,437.10 23,247.50 29,931.40

Alkem Laboratories Quarterly Data
Sep21 Dec21 Mar22 Jun22 Sep22 Dec22 Mar23 Jun23 Sep23 Dec23 Mar24 Jun24 Sep24 Dec24 Mar25 Jun25 Sep25 Dec25 Mar26 Jun26
Other Long Term Assets Get a 7-Day Free Trial Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only Premium Member Only - 20,367.40 - 29,931.40 -
NSE:ALKEM
96GF Score
Alkem Laboratories Ltd NSE:ALKEM
Other Long Term Assets is just one metric. See GF Score™, valuation, warning signs, and more.
View Full Analysis

Alkem Laboratories Other Long Term Assets Calculation

GuruFocus lists Investments And Advances, Intangible Assets, Property, Plant and Equipment and Other Long Term Assets under the "Total Long-Term Assets" section.

Other Long Term Assets includes following items:
Investment in Properties
Non-current Accounts Receivable
Non-current Note Receivables
Non-current Deferred Assets
Non-current Prepaid Assets
Defined Pension Benefit
Other (too numerous to list)
Some companies can do choose to report each of these items separately. Yet, there are a variety of Other Long Term Assets which are simply too numerous to list.

Frequently Asked Questions Learn more about Other Long Term Assets →
What does a Other Long Term Assets of ₹ Mil mean?
Alkem Laboratories (NSE:ALKEM) has a Other Long Term Assets of ₹ Mil as of Jun. 2026. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Alkem Laboratories and its competitors.
Is Alkem Laboratories' Other Long Term Assets too high?
Alkem Laboratories' current Other Long Term Assets is ₹ Mil. Overall, Alkem Laboratories has a GF Score™ of 96/100 and is considered Modestly Undervalued, reflecting its overall financial health beyond just this single metric.
How does Alkem Laboratories' Other Long Term Assets compare to ZTS?
Alkem Laboratories' Other Long Term Assets of ₹ Mil can be compared against companies in the Drug Manufacturers industry. See the competitive comparison table and distribution chart on this page for a detailed peer-by-peer breakdown.
What is a good Other Long Term Assets for a Drug Manufacturers company?
A good Other Long Term Assets depends on the Drug Manufacturers industry context. However, Other Long Term Assets should not be evaluated in isolation — investors should consider it alongside profitability, growth, and financial strength metrics. Use the industry distribution chart on this page to see where any company falls relative to its peers.
What does a high Other Long Term Assets mean?
A high Other Long Term Assets can signal that a stock is expensive relative to its fundamentals. Other long-term assets as record on a company's balance sheet not categorized as standard assets. View historical data on Alkem Laboratories and its competitors. Alkem Laboratories's current Other Long Term Assets is ₹ Mil. However, context matters — high-growth companies often justify higher valuations. Always evaluate alongside other metrics like GF Score™ and GF Value™.
Is Alkem Laboratories stock overvalued right now?
Based on GuruFocus' analysis, Alkem Laboratories (NSE:ALKEM) is currently considered Modestly Undervalued. The stock's GF Value™ is ₹6,174.95, compared to a current price of ₹5,466.50 — trading 11.5% below its estimated fair value. The current Other Long Term Assets is ₹ Mil. Alkem Laboratories' overall GF Score™ is 96/100. Investors should evaluate multiple metrics — including profitability, growth, and financial strength — before making a decision.
How is Other Long Term Assets calculated?
Other Long Term Assets is calculated from a company's financial statements. For Alkem Laboratories (NSE:ALKEM), the current Other Long Term Assets is ₹ Mil as of Jun. 2026. GuruFocus calculates this using data sourced from SEC filings and annual reports. See the calculation section and 30-year financial data on this page for the full breakdown.

Is Alkem Laboratories (NSE:ALKEM) Overvalued in 2026?

Based on GuruFocus' analysis, Alkem Laboratories stock appears to be undervalued. The current stock price of ₹5,466.50 is trading 11.5% below its estimated GF Value™ of ₹6,174.95. GuruFocus considers Alkem Laboratories to be Modestly Undervalued.

Key valuation signals for NSE:ALKEM:

  • Other Long Term Assets: ₹ Mil
  • GF Value™: ₹6,174.95 vs. price of ₹5,466.50 (11.5% below fair value)
  • GF Score™: 96/100

No single metric tells the full story. See the NSE:ALKEM stock analysis page for a complete view including 30-year financials, guru trades, and insider activity.

Alkem Laboratories Business Description

Other Exchanges 539523:India
Address Senapati Bapat Marg, Alkem House, Devashish Building, Lower Parel, Mumbai, MH, IND, 400 013
Alkem Laboratories Ltd is an Indian pharmaceutical company engaged in the development, manufacture, and sale of pharmaceutical and nutraceutical products. The company produces branded generics, generic drugs, active pharmaceutical ingredients (APIs) and nutraceuticals in acute and chronic therapeutic areas, such as anti-infective, pain and analgesics, vitamins/minerals/nutrients, cardiac and Diabetology, Gynecology, neuro/central nervous system, dermatology, anti-diabetes, anti-osteoporosis, cardiovascular, and muscle relaxants, which are marketed in Indian and International markets. It operates through the pharmaceutical business segment.
96GF Score

Get the complete analysis for NSE:ALKEM

Other Long Term Assets is just one metric. See GF Value™, 30-year financials, guru trades, warning signs, and more.

₹5,466.50
Price
₹6,174.95
GF Value